|
IDXG Interpace Biosciences Inc 1054102 |
| Balance Sheet |
|
Current Assets
|
$9,963,000.00 |
|
Assets
|
$33,409,000.00 |
|
Current Liabilities
|
$3,962,000.00 |
|
Liabilities
|
$10,327,000.00 |
|
Equity
|
$23,082,000.00 |
|
Shares Out
|
27700904.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$283,000.00 |
|
Investing Cash Flow
|
$-141,000.00 |
| Market Analysis |
Market Cap
|
$39,889,301.76 |
|
Price
|
$1.52 |
|
BVPS
|
0.83 |
|
PB
|
1.73 |
|
EPS
|
0.03 |
|
PE
|
2.25 |
|
PS
|
1.25 |
|
FCF
|
$142,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:41 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:40 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view IDXG documents filed with the SEC.
IDXG Filings
Clear
